Chief Financial Officer
Matt Norkunas, M.D., joined SomaLogic as Chief Financial Officer in 2016. Prior to joining SomaLogic, Dr. Norkunas spent nearly four years as a Senior Research Analyst at Marsico Capital Management in Denver, Colorado, where he focused on biotech, pharma, life sciences and diagnostics companies. While at Marsico, Dr. Norkunas evaluated companies at both the private and public level, spearheading firm participation in a number of capital market transactions for companies in the space, including secondary equity, IPO, crossover and debt financings.
In addition to his eight years of experience in the venture capital industry, Dr. Norkunas is also a board-certified anesthesiologist. During his medical career, Dr. Norkunas spent three years as the Vice President of New Business Development AABP, a private physician group in New York City. He was voted “teaching attending of the year” by Maimonides (New York) Hospital residents in 2010, and was renowned for his cadaver-lab “teach-ins.” He also actively participated in various clinical trials, published in peer-reviewed journals and developed two patents (pending) for medical devices.
Dr. Norkunas received his anesthesia training at Mount Sinai in New York, and earned his M.D. from the University of Maryland Medical School, his M.B.A. from Columbia University, and his B.A. in Biology from St. Mary’s College of Maryland.